These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7456427)
21. A study of ovarian cancer patients using a radioimmunoassay for human ovarian tumor-associated antigen OCA. Knauf S; Urbach GI Am J Obstet Gynecol; 1980 Dec; 138(8):1222-3. PubMed ID: 7446632 [No Abstract] [Full Text] [Related]
22. Possibility of immunodiagnosis in ovarian cancer. Chin Med J (Engl); 1978 May; 4(3):185-90. PubMed ID: 98299 [No Abstract] [Full Text] [Related]
23. Peritoneal fluid lactate dehydrogenase in ovarian cancer. Schneider D; Halperin R; Langer R; Bukovsky I; Herman A Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252 [TBL] [Abstract][Full Text] [Related]
24. Immunophenotype of human ovarian malignancies (cystadenocarcinomata and mixed müllerian tumor) established in SCID mice. Schumacher U; Adam E; Dietl J; Horny HP Exp Mol Pathol; 1997 Apr; 64(2):103-13. PubMed ID: 9316588 [TBL] [Abstract][Full Text] [Related]
25. Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer. Gamzatova Z; Villabona L; Dahlgren L; Dalianis T; Nillson B; Bergfeldt K; Masucci GV Gynecol Oncol; 2006 Oct; 103(1):145-50. PubMed ID: 16542716 [TBL] [Abstract][Full Text] [Related]
26. Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients. Chinni SR; Falchetto R; Gercel-Taylor C; Shabanowitz J; Hunt DF; Taylor DD Clin Cancer Res; 1997 Sep; 3(9):1557-64. PubMed ID: 9815843 [TBL] [Abstract][Full Text] [Related]
28. [ZNF217 gene was detected in ovarian serous cystadenocarcinoma by fluorescence in situ hybridization]. Zhong M; Li J; Ding YQ; Song LL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):665-7. PubMed ID: 17160949 [TBL] [Abstract][Full Text] [Related]
29. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180 [TBL] [Abstract][Full Text] [Related]
30. Studies on xenogenic antisera to tumor-associated antigen of ovarian carcinoma. Gerber MA; Faiferman I; Cohen CJ; Koffler D Clin Immunol Immunopathol; 1977 Sep; 8(2):171-80. PubMed ID: 198173 [No Abstract] [Full Text] [Related]
31. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma. Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502 [TBL] [Abstract][Full Text] [Related]
32. Myeloid and lymphoid dendritic cells in the peritoneal fluid of women with ovarian cancer. Wertel F; Polak G; Roliński J; Barczyński B; Kotarski J Adv Med Sci; 2006; 51():174-7. PubMed ID: 17357302 [TBL] [Abstract][Full Text] [Related]
33. Investigation of Vicia graminea lectin- and Vicia unijuga lectin-binding glycoproteins as novel oncofetal antigens in cyst and ascitic fluids of human ovarian tumors in benign, dysplastic, and malignant stages. Ohyama K; Yanagi K; Hayashi S; Matsuda T; Suzuki R; Ohkuma S; Watanabe H; Hirakawa S; Yamakawa T Cancer Detect Prev; 1997; 21(4):304-11. PubMed ID: 9232320 [TBL] [Abstract][Full Text] [Related]
34. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms. Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148 [TBL] [Abstract][Full Text] [Related]
37. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression. Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951 [TBL] [Abstract][Full Text] [Related]
38. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS. Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763 [TBL] [Abstract][Full Text] [Related]
39. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors. Choi YL; Kim SH; Shin YK; Hong YC; Lee SJ; Kang SY; Ahn G Gynecol Oncol; 2005 May; 97(2):379-86. PubMed ID: 15863133 [TBL] [Abstract][Full Text] [Related]
40. [The construction and expression of 6B11scFv anti-idiotypic antibody and human granulocyte-macrophage-colony stimulating factor in Escherichia coli]. Yang F; Qian H; Huang H Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):417-9. PubMed ID: 11360654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]